Human CA19-9(Carbohydrate antigen19-9) CLIA Kit

The Human CA19-9 (Carbohydrate antigen19-9) CLIA Kit is a highly advanced and reliable diagnostic tool designed for the detection of CA19-9 in human serum or plasma samples. This kit is based on the Chemiluminescent Immunoassay (CLIA) technology, which ensures high sensitivity and specificity of the test results. The kit is intended for use in clinical laboratories and research facilities for the diagnosis and monitoring of various types of cancers, including pancreatic, colorectal, and gastric cancers.

The Human CA19-9 CLIA Kit is easy to use and provides accurate and reproducible results within a short period of time. The kit contains all the necessary reagents and components required for the assay, including microplates, standards, controls, and detection reagents. The assay procedure involves the binding of CA19-9 present in the sample to the specific antibodies coated on the microplate, followed by the addition of detection reagents that generate a chemiluminescent signal. The signal is then measured using a luminometer, and the concentration of CA19-9 in the sample is determined based on the standard curve.

The Human CA19-9 CLIA Kit is manufactured in compliance with the highest quality standards and is CE-marked for in vitro diagnostic use. It offers a reliable and cost-effective solution for the detection of CA19-9 in human serum or plasma samples, making it an essential tool for cancer diagnosis and monitoring.